Phase II trial of patupilone in patients with brain metastases from breast cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase II trial of patupilone in patients with brain metastases from breast cancer
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume 16, Issue 4, Pages 579-583
Publisher
Oxford University Press (OUP)
Online
2014-01-28
DOI
10.1093/neuonc/not305
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tubulin-β-III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones
- (2013) Dana M. Roque et al. CANCER
- Population-based outcomes after brain radiotherapy in patients with brain metastases from breast cancer in the Pre-Trastuzumab and Trastuzumab eras
- (2013) Irene Karam et al. Radiation Oncology
- Gli family transcription factors are drivers of patupilone resistance in ovarian cancer
- (2012) Simona Mozzetti et al. BIOCHEMICAL PHARMACOLOGY
- Patupilone (Epothilone B) for Recurrent Glioblastoma: Clinical Outcome and Translational Analysis of a Single-Institution Phase I/II Trial
- (2012) Christoph Oehler et al. ONCOLOGY
- A phase 2 study of patupilone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Canadian Urologic Oncology Group study P07a
- (2011) K. N. Chi et al. ANNALS OF ONCOLOGY
- A Phase II Study of Sagopilone (ZK 219477; ZK-EPO) in Patients With Breast Cancer and Brain Metastases
- (2011) Rachel A. Freedman et al. Clinical Breast Cancer
- Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients with Advanced Malignancies: A Phase I Clinical Trial
- (2011) A.-M. Tsimberidou et al. MOLECULAR CANCER THERAPEUTICS
- Specific β-Tubulin Isotypes Can Functionally Enhance or Diminish Epothilone B Sensitivity in Non-Small Cell Lung Cancer Cells
- (2011) Pei Pei Gan et al. PLoS One
- Patupilone in cancer treatment
- (2010) Branislav Bystricky et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study
- (2009) S. Siena et al. ANNALS OF ONCOLOGY
- Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer
- (2009) N. U. Lin et al. CLINICAL CANCER RESEARCH
- Phase I Trial Using Patupilone (Epothilone B) and Concurrent Radiotherapy for Central Nervous System Malignancies
- (2009) Shannon Fogh et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo
- (2008) Terence O’Reilly et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase II Trial of Lapatinib for Brain Metastases in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- (2008) Nancy U. Lin et al. JOURNAL OF CLINICAL ONCOLOGY
- Brain metastases in breast cancer: clinical and pathologic characteristics associated with improvements in survival
- (2008) Michelle E. Melisko et al. JOURNAL OF NEURO-ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started